Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Lower growth factor expression in follicular fluid undergone in-vitro fertilization

  • Han, Myoung-Seok (Department of Obstetrics and Gynecology, Dong-A University Hospital, Dong-A University School of Medicine) ;
  • Park, Seung-Bin (Department of Obstetrics and Gynecology, Dong-A University Hospital, Dong-A University School of Medicine) ;
  • Park, Bang-Ja (Infertility Clinic, Dong-A University Hospital, Dong-A University School of Medicine)
  • Received : 2011.11.09
  • Accepted : 2011.12.26
  • Published : 2011.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This study was performed to identify whether growth and differentiation factor-9 (GDF-9) and transforming growth factor-${\beta}1$ (TGF-${\beta}1$) expressions would be lower in the follicular fluid (FF) of those over age 35 who underwent IVF than under age 35. Methods: A total of 24 IVF cycles (20 patients) were included in this study. All of patients were stimulated for IVF by the GnRH short protocol and divided into two groups for analysis, according to their age: <35 group (14 cycles, 11 patients) vs. ${\geq}35$ group (10 cycles, 9 patients). The expression levels of GDF-9 and TGF-${\beta}1$ were determined by western blotting and quantitative enzyme-linked immunosorbent assay. Results: The numbers of retrieved oocytes and metaphase II oocytes were significantly lower in the ${\geq}35$ group. Lower expression of GDF-9 and TGF-${\beta}1$ by western blotting in the ${\geq}35$ group were observed as well. The mean GDF-9 and TGF-${\beta}1$ levels by enzyme-linked immunosorbent assay were lower in the ${\geq}35$ group. The values were $6,850.5{\pm}928.4$ ng/L vs. $3,333.3{\pm}1,089.2$ ng/L of GDF-9 ($p$ <0.05) and $3,844.1{\pm}571.1$ ng/L vs. $2,187.7{\pm}754.0$ ng/L of TGF-${\beta}1$ ($p$ <0.05). A negative correlation between GDF-9 and age was observed (r=-0.546, $p$=0.006). Conclusion: GDF-9 and TGF-${\beta}1$ production from stimulated ovaries during IVF appears to decrease with age.

Keywords

References

  1. Wood JW. Fecundity and natural fertility in humans. Oxf Rev Reprod Biol 1989;11:61-109.
  2. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141-54. https://doi.org/10.1093/humupd/8.2.141
  3. American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2005 Assisted reproductive technology success rates: national summary and fertility clinic reports. Atlanta: Centers for Disease Control and Prevention, 2007.
  4. Aaltonen J, Laitinen MP, Vuojolainen K, Jaatinen R, Horelli-Kuitunen N, Seppa L, et al. Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J Clin Endocrinol Metab 1999;84:2744-50. https://doi.org/10.1210/jc.84.8.2744
  5. Juengel JL, Bodensteiner KJ, Heath DA, Hudson NL, Moeller CL, Smith P, et al. Physiology of GDF9 and BMP15 signalling molecules. Anim Reprod Sci 2004;82-83:447-60. https://doi.org/10.1016/j.anireprosci.2004.04.021
  6. Hreinsson JG, Scott JE, Rasmussen C, Swahn ML, Hsueh AJ, Hovatta O. Growth differentiation factor-9 promotes the growth, development, and survival of human ovarian follicles in organ culture. J Clin Endocrinol Metab 2002;87:316-21. https://doi.org/10.1210/jc.87.1.316
  7. Orisaka M, Orisaka S, Jiang JY, Craig J, Wang Y, Kotsuji F, et al. Growth differentiation factor 9 is antiapoptotic during follicular development from preantral to early antral stage. Mol Endocrinol 2006;20:2456-68. https://doi.org/10.1210/me.2005-0357
  8. Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction 2006;132:191-206. https://doi.org/10.1530/rep.1.01074
  9. Fried G, Wramsby H. Increase in transforming growth factor beta1 in ovarian follicular fluid following ovarian stimulation and in-vitro fertilization correlates to pregnancy. Hum Reprod 1998;13:656-9. https://doi.org/10.1093/humrep/13.3.656
  10. Mulheron GW, Bossert NL, Lapp JA, Walmer DK, Schomberg DW. Human granulosa-luteal and cumulus cells express transforming growth factors-beta type 1 and type 2 mRNA. J Clin Endocrinol Metab 1992;74:458-60. https://doi.org/10.1210/jc.74.2.458
  11. Brogan RS, Mix S, Puttabyatappa M, VandeVoort CA, Chaffin CL. Expression of the insulin-like growth factor and insulin systems in the luteinizing macaque ovarian follicle. Fertil Steril 2010;93:1421-9. https://doi.org/10.1016/j.fertnstert.2008.12.096
  12. Bleach EC, Glencross RG, Feist SA, Groome NP, Knight PG. Plasma inhibin A in heifers: relationship with follicle dynamics, gonadotropins, and steroids during the estrous cycle and after treatment with bovine follicular fluid. Biol Reprod 2001;64:743-52. https://doi.org/10.1095/biolreprod64.3.743
  13. Evers JL. Female subfertility. Lancet 2002;360:151-9. https://doi.org/10.1016/S0140-6736(02)09417-5
  14. Gilchrist RB, Thompson JG. Oocyte maturation: emerging concepts and technologies to improve developmental potential in vitro. Theriogenology 2007;67:6-15. https://doi.org/10.1016/j.theriogenology.2006.09.027
  15. McNatty KP, Hudson NL, Whiting L, Reader KL, Lun S, Western A, et al. The effects of immunizing sheep with different BMP15 or GDF9 peptide sequences on ovarian follicular activity and ovulation rate. Biol Reprod 2007;76:552-60. https://doi.org/10.1095/biolreprod.106.054361
  16. Juengel JL, Bibby AH, Reader KL, Lun S, Quirke LD, Haydon LJ, et al. The role of transforming growth factor-beta (TGF-beta) during ovarian follicular development in sheep. Reprod Biol Endocrinol 2004;2:78. https://doi.org/10.1186/1477-7827-2-78
  17. Nilsson EE, Doraiswamy V, Skinner MK. Transforming growth factor-beta isoform expression during bovine ovarian antral follicle development. Mol Reprod Dev 2003;66:237-46. https://doi.org/10.1002/mrd.10350
  18. Juengel JL, McNatty KP. The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum Reprod Update 2005;11:143-60.
  19. Gode F, Gulekli B, Dogan E, Korhan P, Dogan S, Bige O, et al. Influence of follicular fluid GDF9 and BMP15 on embryo quality. Fertil Steril 2011;95:2274-8. https://doi.org/10.1016/j.fertnstert.2011.03.045
  20. Wen X, Tozer AJ, Butler SA, Bell CM, Docherty SM, Iles RK. Follicular fluid levels of inhibin A, inhibin B, and activin A levels reflect changes in follicle size but are not independent markers of the oocyte's ability to fertilize. Fertil Steril 2006;85:1723-9. https://doi.org/10.1016/j.fertnstert.2005.11.058
  21. Fried G, Remaeus K, Harlin J, Krog E, Csemiczky G, Aanesen A, et al. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization. J Assist Reprod Genet 2003;20:167-76. https://doi.org/10.1023/A:1023656225053
  22. Menken J, Trussell J, Larsen U. Age and infertility. Science 1986;233:1389-94. https://doi.org/10.1126/science.3755843

Cited by

  1. A Proteomic Analysis of Human Follicular Fluid: Comparison between Younger and Older Women with Normal FSH Levels vol.15, pp.10, 2011, https://doi.org/10.3390/ijms151017518
  2. Regulation of AMH by oocyte-specific growth factors in human primary cumulus cells vol.154, pp.6, 2011, https://doi.org/10.1530/rep-17-0421
  3. Assisted reproductive technique in women of advanced fertility age vol.70, pp.6, 2018, https://doi.org/10.23736/s0026-4784.18.04247-8
  4. Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 During IVF and in Women With Reproductive Pathologies vol.160, pp.10, 2011, https://doi.org/10.1210/en.2019-00264